Literature DB >> 7977642

Cytokine responses during mycobacterial and schistosomal antigen-induced pulmonary granuloma formation. Production of Th1 and Th2 cytokines and relative contribution of tumor necrosis factor.

S W Chensue1, K Warmington, J Ruth, P Lincoln, M C Kuo, S L Kunkel.   

Abstract

Synchronized pulmonary granulomas (GRs) were induced in presensitized mice by intravenous embolization of polymer beads bound with purified protein derivative (PPD) of Mycobacteria tuberculosis or soluble antigens derived from Schistosoma mansoni eggs (SEA). Uncoated beads served as a foreign body control (CON). Antigen-coated beads elicited GRs with characteristic epithelioid macrophages and multinucleate giant cells by 4 days after embolization. Unlike PPD GR, SEA bead lesions contained eosinophils, whereas CON beads elicited only a limited mononuclear infiltrate. GRs and draining lymph nodes (LN) were assessed on days 2, 4, and 8 for Th1-(interleukin-2 [IL-2], interferon-gamma[IFN] and Th2-type (IL-4, IL-5, and IL-10) cytokines. CON GR produced only a small amount of IFN-gamma on day 2 and failed to induce a significant response in draining LN. In contrast, both PPD and SEA antigen-coated beads induced reactive lymphoid hyperplasia but differed greatly in local and regional cytokine profiles. PPD GR produced IFN-gamma on day 2 and the draining LN produced predominantly Th1 cytokines on days 2 and 4. In contrast, SEA beads GRs were dominated by Th2 cytokines. The corresponding LN produced IL-2 and IL-4 on day 2; IL-2, IL-4, IFN-gamma, and IL-10 on day 4; then IL-2, IFN-gamma, and IL-4 on day 8, probably reflecting maturational changes of T cells. Macrophages (MP) from bead GR also showed different patterns of IL-6 and tumor necrosis factor (TNF) production. Compared with CON GR, MPs from PPD GR were weak sources of IL-6, whereas those of SEA GR showed enhanced and accelerated production. In contrast, MP of PPD GR had augmented TNF-producing capacity, whereas those of SEA GR showed delayed TNF production. In vivo depletion of TNF, respectively, caused 40 and 10% decreases in PPD GR and SEA GR but had no effect on CON GR area, indicating that TNF contributed to a greater degree to the PPD response. These data show that depending on the inciting agent, GR can be mediated by different cytokines. Characterization of inflammatory lesions by cytokine profiles should allow design of more rational therapeutic interventions.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7977642      PMCID: PMC1887419     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  36 in total

1.  IL-4 down-regulates IL-1 and TNF gene expression in human monocytes.

Authors:  R Essner; K Rhoades; W H McBride; D L Morton; J S Economou
Journal:  J Immunol       Date:  1989-06-01       Impact factor: 5.422

2.  Derivation of a T cell line that is highly responsive to IL-4 and IL-2 (CT.4R) and of an IL-2 hyporesponsive mutant of that line (CT.4S).

Authors:  J Hu-Li; J Ohara; C Watson; W Tsang; W E Paul
Journal:  J Immunol       Date:  1989-02-01       Impact factor: 5.422

3.  Monokine production by hypersensitivity (Schistosoma mansoni egg) and foreign body (Sephadex bead)-type granuloma macrophages. Evidence for sequential production of IL-1 and tumor necrosis factor.

Authors:  S W Chensue; I G Otterness; G I Higashi; C S Forsch; S L Kunkel
Journal:  J Immunol       Date:  1989-02-15       Impact factor: 5.422

4.  A sensitive immunochemical assay for biologically active MuIFN-gamma.

Authors:  R C Curry; P A Kiener; G L Spitalny
Journal:  J Immunol Methods       Date:  1987-11-23       Impact factor: 2.303

5.  An improved colorimetric assay for interleukin 2.

Authors:  H Tada; O Shiho; K Kuroshima; M Koyama; K Tsukamoto
Journal:  J Immunol Methods       Date:  1986-11-06       Impact factor: 2.303

6.  Flow-cytometric evaluation of lymphocyte subpopulations in synchronously developing Schistosoma mansoni egg and Sephadex bead pulmonary granulomas.

Authors:  D G Remick; S W Chensue; J C Hiserodt; G I Higashi; S L Kunkel
Journal:  Am J Pathol       Date:  1988-05       Impact factor: 4.307

7.  The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection.

Authors:  V Kindler; A P Sappino; G E Grau; P F Piguet; P Vassalli
Journal:  Cell       Date:  1989-03-10       Impact factor: 41.582

8.  Immunohistochemical demonstration of cytoplasmic and membrane-associated tumor necrosis factor in murine macrophages.

Authors:  S W Chensue; D G Remick; C Shmyr-Forsch; T F Beals; S L Kunkel
Journal:  Am J Pathol       Date:  1988-12       Impact factor: 4.307

9.  Activation of gamma delta T cells in the primary immune response to Mycobacterium tuberculosis.

Authors:  E M Janis; S H Kaufmann; R H Schwartz; D M Pardoll
Journal:  Science       Date:  1989-05-12       Impact factor: 47.728

10.  Gamma interferon enhances macrophage transcription of the tumor necrosis factor/cachectin, interleukin 1, and urokinase genes, which are controlled by short-lived repressors.

Authors:  M A Collart; D Belin; J D Vassalli; S de Kossodo; P Vassalli
Journal:  J Exp Med       Date:  1986-12-01       Impact factor: 14.307

View more
  39 in total

1.  Polarization of the immune response to the single immunodominant epitope of p38, a major Schistosoma mansoni egg antigen, generates Th1- or Th2-type cytokines and granulomas.

Authors:  Y Chen; D L Boros
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

2.  Generation of multinucleated giant cells in vitro by culture of human monocytes with Mycobacterium bovis BCG in combination with cytokine-containing supernatants.

Authors:  A Gasser; J Möst
Journal:  Infect Immun       Date:  1999-01       Impact factor: 3.441

3.  Development of a sarcoidosis murine lung granuloma model using Mycobacterium superoxide dismutase A peptide.

Authors:  Carmen M Swaisgood; Kyra Oswald-Richter; Stephen D Moeller; Jennifer M Klemenc; Lisa M Ruple; Carol F Farver; John M Drake; Daniel A Culver; Wonder P Drake
Journal:  Am J Respir Cell Mol Biol       Date:  2010-03-26       Impact factor: 6.914

4.  CC chemokine receptor 4 contributes to innate NK and chronic stage T helper cell recall responses during Mycobacterium bovis infection.

Authors:  Valerie R Stolberg; Bo-Chin Chiu; Brian M Schmidt; Steven L Kunkel; Matyas Sandor; Stephen W Chensue
Journal:  Am J Pathol       Date:  2010-12-23       Impact factor: 4.307

5.  TLR9 regulates the mycobacteria-elicited pulmonary granulomatous immune response in mice through DC-derived Notch ligand delta-like 4.

Authors:  Toshihiro Ito; Matthew Schaller; Cory M Hogaboam; Theodore J Standiford; Matyas Sandor; Nicholas W Lukacs; Stephen W Chensue; Steven L Kunkel
Journal:  J Clin Invest       Date:  2008-12-15       Impact factor: 14.808

6.  Overexpression of CIITA in T cells aggravates Th2-mediated colitis in mice.

Authors:  Tae Woon Kim; Hyo Jin Park; Eun Young Choi; Kyeong Cheon Jung
Journal:  J Korean Med Sci       Date:  2006-10       Impact factor: 2.153

Review 7.  Cutaneous lesions of the nose.

Authors:  Michael Sand; Daniel Sand; Christina Thrandorf; Volker Paech; Peter Altmeyer; Falk G Bechara
Journal:  Head Face Med       Date:  2010-06-04       Impact factor: 2.151

8.  Identification of key processes that control tumor necrosis factor availability in a tuberculosis granuloma.

Authors:  Mohammad Fallahi-Sichani; Matthew A Schaller; Denise E Kirschner; Steven L Kunkel; Jennifer J Linderman
Journal:  PLoS Comput Biol       Date:  2010-05-06       Impact factor: 4.475

9.  Collagen deposition in a non-fibrotic lung granuloma model after nitric oxide inhibition.

Authors:  C M Hogaboam; C S Gallinat; C Bone-Larson; S W Chensue; N W Lukacs; R M Strieter; S L Kunkel
Journal:  Am J Pathol       Date:  1998-12       Impact factor: 4.307

10.  The lung vascular filter as a site of immune induction for T cell responses to large embolic antigen.

Authors:  Monique A M Willart; Hendrik Jan de Heer; Hamida Hammad; Thomas Soullié; Kim Deswarte; Björn E Clausen; Louis Boon; Henk C Hoogsteden; Bart N Lambrecht
Journal:  J Exp Med       Date:  2009-10-26       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.